Marc Scheineson discusses how the Food and Drug Administration’s review process could still help Philip Morris’s application to sell its iQOS smokeless tobacco stick in the U.S.
In the News
January 25, 2018
CNBC | Philip Morris Could Win Even if Its iQOS Marketing Application Fails
Media Contact